Viewing Study NCT04157933


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2026-01-07 @ 1:10 AM
Study NCT ID: NCT04157933
Status: COMPLETED
Last Update Posted: 2020-11-04
First Post: 2019-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease
Sponsor: Alexza Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module